Announcements Trials

Browse Landscape

Phase

Phase 1 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 31 Precursor Cell Lymphoblastic Leukemia-Lymphoma 21 Leukemia, Myeloid, Chronic-Phase 17 Leukemia 12 Breast Neoplasms 12 Prostatic Neoplasms 10 Neoplasm Metastasis 8 Recurrence 6 Pancreatic Neoplasms 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Carcinoma, Non-Small-Cell Lung 6 Melanoma 5 Lung Neoplasms 5 Leukemia, Myeloid, Acute 5 Philadelphia Chromosome 4 Multiple Myeloma 4 Lymphoma 4 Burkitt Lymphoma 4 Blast Crisis 4 Squamous Cell Carcinoma of Head and Neck 3 Rectal Neoplasms 3 Ovarian Neoplasms 3 Glioma 3 Colonic Neoplasms 3 Triple Negative Breast Neoplasms 2 Salivary Gland Neoplasms 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Polycythemia Vera 2 Neuroblastoma 2 Leukemia, Myelomonocytic, Chronic 2

Interventions

Temozolomide 7 Radiotherapy 3 Everolimus 3 nimotuzumab 2 Erlotinib Hydrochloride 2 Cyclophosphamide 2 Bevacizumab 2 tovorafenib 1 ribociclib 1 palbociclib 1 olutasidenib 1 antineoplaston AS 2-1 1 antineoplaston A10 1 Vinorelbine 1 Valproic Acid 1 Topotecan 1 TIC10 compound 1 Radiation 1 Proto-Oncogene Proteins c-akt 1 Phosphatidylinositol 3-Kinases 1 Panobinostat 1 Lomustine 1 Irinotecan 1 Injections 1 GDC-0084 1 Etoposide 1 Drug Therapy 1 Doxorubicin 1 Diphtheria-Tetanus Vaccine 1 Dasatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Diffuse Intrinsic Pontine Glioma × Dasatinib × Clear all

NCT02233049 2018-07-23

BIOMEDE

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Unknown

Diffuse Intrinsic Pontine Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡